Zhi H. Huang, et.al., Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation., Journal of lipid research, 2015, 56

http://rdf.ncbi.nlm.nih.gov/pubmed/25421060

Zhi H. Huang, et.al., Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation., Journal of lipid research, 2015, 56

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Apoe<tm1.1Mae>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5703874

class

http://purl.org/net/cito/citesAsAuthority

• Apoe<tm1.1Mae>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5703874

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased circulating triglyceride level_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0002644B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• decreased circulating insulin level_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0002727B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• increased insulin sensitivity_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0002891B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• decreased macrophage cell number_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0003884B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• increased cholesterol level_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0003982B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• decreased cholesterol level_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0003983B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
他10件を見る
• decreased circulating cholesterol level_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0005179B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• improved glucose tolerance_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0005292B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• decreased triglyceride level_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0005318B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• increased macrophage cell number_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0005425B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• decreased circulating glucose level_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0005560B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• decreased white fat cell lipid droplet size_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0009122B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• decreased white fat cell size_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0009133B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• decreased epididymal fat pad weight_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0009289B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• decreased liver triglyceride level_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0009356B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae
• decreased liver cholesterol level_Apoe<tm1.1Mae>/Apoe<tm1.1Mae>,Tg(Fabp4-cre)1Rev/0
  http://metadb.riken.jp/0010026B6CgApoetm11MaeTgFabp4cre1RevApoetm11MaeApoetm11MaeTgFabp4cre1Rev0TgFabp4cre1RevApoetm11Mae